Status:
COMPLETED
CAPTURER PMCF Study ( rEPIC04D )
Lead Sponsor:
Fundación EPIC
Conditions:
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of CAPTURER to meet EU Medical Device regulation (MDR) ...
Detailed Description
The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the CAPTURER in a NON-SELEC...
Eligibility Criteria
Inclusion
- Patient treated with CAPTURER according to routine hospital practice and following instructions for use
- Informed consent signed
Exclusion
- Not meet inclusion criteria
Key Trial Info
Start Date :
September 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 27 2023
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT05292079
Start Date
September 29 2022
End Date
December 27 2023
Last Update
November 22 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Puerta Del Mar
Cadiz, Spain, 11009
2
Hospital de San Pedro
Logroño, Spain, 26006
3
Hospital Universitario Regional de Malaga
Málaga, Spain, 29010
4
Hospital Universitario Virgen de La Victoria
Málaga, Spain, 29010